To further confirm the effect of α7nAChR-mediated Nrf2/HO-1 pathway in sepsis, the potential anti-inflammatory mechanism of remimazolam was investigated via MLA and ML385 treatment. The gene discussed is CHRNA7; the disease is Sepsis.